ELITE PHARMACEUTICALS, INC.

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

May 11, 2007

Accession Number

0000902664-07-001698

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →